The development of durable HIV-1 therapeutics requires understanding not only which mutations confer resistance, but also how readily those mutations arise. Prior work has characterized the effects of individual mutations on viral fitness and drug or immune escape; however, the contribution of mutational bias to HIV-1 evolutionary pathways remains largely unquantified. Here, we report and provide…
A new study led by experts at the University of Nottingham has provided new insight into how a commonly used test for colorectal cancer performs in people under 50.